Vantrexa · NSCLC · France · Pathologist · captured by James Whitfield on 23 Apr 2026 · reviewed by Dr. Sophie Laurent on 28 Apr 2026
Verbatim as captured; never edited
Pathologist at Hôpital Pitié-Salpêtrière raised duration of response during a medical education. They noted that colleagues in their network share the view.
Human-approved by Dr. Sophie Laurent on 28 Apr 2026
Duration of response: gap in current materials reported by pathologist (FR).
No AI assistance
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 4 | 20% | 16.0 |
| Strategic alignment | 1 | 20% | 4.0 |
| Scientific importance | 2 | 15% | 6.0 |
| Urgency | 3 | 15% | 9.0 |
| Novelty | 5 | 10% | 10.0 |
| Actionability | 5 | 10% | 10.0 |
| Confidence | 2 | 5% | 2.0 |
| Breadth of occurrence | 4 | 5% | 4.0 |
| Total | Medium 61 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
23 Apr 2026 · Dr. Ulrich Abbott, Hôpital Pitié-Salpêtrière · MSL James Whitfield
Insight
Reviewed 28 Apr 2026 by Dr. Sophie Laurent
Action
Publication project · David Chen · In progress
Decision
Outcome
Closure
Shared with Clinical Development; no further action required.